Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Front Immunol ; 13: 1072702, 2022.
Article in English | MEDLINE | ID: mdl-36569848

ABSTRACT

The diversity of three hypervariable loops in antibody heavy chain and light chain, termed the complementarity-determining regions (CDRs), defines antibody's binding affinity and specificity owing to the direct contact between the CDRs and antigens. These CDR regions typically contain tyrosine (Tyr) residues that are known to engage in both nonpolar and pi stacking interaction with antigens through their complementary aromatic ring side chains. Nearly two decades ago, sulfotyrosine residue (sTyr), a negatively charged Tyr formed by Golgi-localized membrane-bound tyrosylprotein sulfotransferases during protein trafficking, were also found in the CDR regions and shown to play an important role in modulating antibody-antigen interaction. This breakthrough finding demonstrated that antibody repertoire could be further diversified through post-translational modifications, in addition to the conventional genetic recombination. This review article summarizes the current advances in the understanding of the Tyr-sulfation modification mechanism and its application in potentiating protein-protein interaction for antibody engineering and production. Challenges and opportunities are also discussed.


Subject(s)
Complementarity Determining Regions , Immunoglobulin Heavy Chains , Complementarity Determining Regions/genetics , Immunoglobulin Heavy Chains/genetics , Antigens , Golgi Apparatus/metabolism , Tyrosine/metabolism
2.
Immunology ; 159(4): 373-383, 2020 04.
Article in English | MEDLINE | ID: mdl-31821535

ABSTRACT

The anti-tumor immune response is considered to be due to the T-cell receptor (TCR) binding to tumor antigens, which can be either wild-type, early stem cell proteins, presumably foreign to a developed immune system; or mutant peptides, foreign to the immune system because of a mutant amino acid (aa) or otherwise somatically altered aa sequence. Recently, very large numbers of TCR complementarity-determining region-3 (CDR3) aa sequences obtained from tumor specimens have become available. We developed a novel algorithm for assessing the complementarity of tumor mutant peptides and TCR CDR3s, based on the retrieval of TCR CDR3 aa sequences from both tumor specimen and patient blood exomes and by using an automated process of assessing CDR3 and mutant aa electrical charges. Results indicated many instances where high electrostatic complementarity was associated with a higher survival rate. In particular, our approach led to the identification of specific genes contributing significantly to the complementary, TCR CDR3-mutant aa. These results suggest a novel approach to tumor immunoscoring and may lead to the identification of high-priority neo-antigen, peptide vaccines; or to the identification of ex vivo stimulants of tumor-infiltrating lymphocytes.


Subject(s)
Algorithms , Antigens, Neoplasm/chemistry , Breast Neoplasms/genetics , Complementarity Determining Regions/chemistry , Lung Neoplasms/genetics , Receptor-CD3 Complex, Antigen, T-Cell/chemistry , Skin Neoplasms/genetics , Amino Acid Sequence , Amino Acids , Antigens, Neoplasm/genetics , Antigens, Neoplasm/immunology , Binding Sites , Breast Neoplasms/diagnosis , Breast Neoplasms/immunology , Breast Neoplasms/mortality , Complementarity Determining Regions/genetics , Complementarity Determining Regions/immunology , Exome , Female , Gene Expression , Humans , Lung Neoplasms/diagnosis , Lung Neoplasms/immunology , Lung Neoplasms/mortality , Male , Mutation , Prognosis , Protein Binding , Receptor-CD3 Complex, Antigen, T-Cell/genetics , Receptor-CD3 Complex, Antigen, T-Cell/immunology , Research Design , Skin Neoplasms/diagnosis , Skin Neoplasms/immunology , Skin Neoplasms/mortality , Static Electricity , Survival Rate , T-Lymphocytes/immunology , T-Lymphocytes/pathology
3.
Front Immunol ; 9: 2278, 2018.
Article in English | MEDLINE | ID: mdl-30386328

ABSTRACT

Monoclonal antibodies are playing an increasing role in both human and animal health. Different strategies of protein and chemical engineering, including humanization techniques of non-human antibodies were applied successfully to optimize clinical performances of antibodies. Despite the emergence of techniques allowing the development of fully human antibodies such as transgenic Xeno-mice, antibody humanization remains a standard procedure for therapeutic antibodies. An important prerequisite for antibody humanization requires standardized numbering methods to define precisely complementary determining regions (CDR), frameworks and residues from the light and heavy chains that affect the binding affinity and/or specificity of the antibody-antigen interaction. The recently generated deep-sequencing data and the increasing number of solved three-dimensional structures of antibodies from human and non-human origins have led to the emergence of numerous databases. However, these different databases use different numbering conventions and CDR definitions. In addition, the large fluctuation of the variable chain lengths, especially in CDR3 of heavy chains (CDRH3), hardly complicates the comparison and analysis of antibody sequences and the identification of the antigen binding residues. This review compares and discusses the different numbering schemes and "CDR" definition that were established up to date. Furthermore, it summarizes concepts and strategies used for numbering residues of antibodies and CDR residues identification. Finally, it discusses the importance of specific sets of residues in the binding affinity and/or specificity of immunoglobulins.


Subject(s)
Amino Acids/immunology , Antibodies, Monoclonal/immunology , Complementarity Determining Regions/immunology , Immunoglobulin Heavy Chains/immunology , Immunoglobulin Light Chains/immunology , Amino Acid Sequence , Amino Acids/chemistry , Amino Acids/genetics , Animals , Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/genetics , Complementarity Determining Regions/chemistry , Complementarity Determining Regions/genetics , Humans , Immunoglobulin Heavy Chains/chemistry , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Light Chains/chemistry , Immunoglobulin Light Chains/genetics , Mice , Protein Domains
4.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 36(6): 735-43, 2016 Jun.
Article in Chinese | MEDLINE | ID: mdl-27491235

ABSTRACT

OBJECTIVE: To observe anti-cancer effects of Jianpi Jiedu Recipe (JJR) on liver cancer (LC) rats with Pi deficiency syndrome (PDS) and its relation with the third complementary-determining region gene spectratyping of TCRVß-chain (TCRVßCDR3). METHODS: Rats were divided into 8 groups according to random digit table, i.e., the blank control group (normal), the PDS group, the LC model group, the LC-PDS group, high, middle, and low dose JJR groups (75.00, 37.50, 18.75 g/kg, respectively by gastrogavage, once per day), the thymus pentapeptide group (5 mg/kg, intramuscular injection, twice per week), 8 in each group. Rats in the normal group were administered with physiological saline by gastrogavage once per day. PDS rat model was prepared by bitter-cold purgation. LC model was prepared by orthotopic transplantation method. Twenty gene subfamilies of TCRßCDR3 in the thymus, liver, and LC tissues were detected by Gene Scan. RESULTS: High and middle dose JJR could postpone the growth of LC volume (P < 0.05), with equivalent liver index and thymus index to those of the normal group (P > 0.05). In thymus and liver tissue of the normal group, the number of clones (20 and 19), gene fragment number (220 and 113), Quasi-Gaussian distribution ratio of TCRVßCDR3 gene repertoire (100.0% and 42.1%), and fragment fluorescence peak area (6,539 ± 2,325 and 1,238 ± 439) were at the highest level among the 8 groups. TCRVßCDR3 expressions in thymus and liver tissue of high and middle dose JJR groups were approximate to those of the normal group. They were in the middle of the thymus pentapeptide group, the PDS group, the LC model group, and poorest in the LC-PDS group. TCRVßCDR3 in liver tissue expressed the best in the thymus pentapeptide group. CONCLUSION: JJR might inhibit the growth of LC cells, and its mechanism might be related to enhancing TCRVßCDR3 spectratype expression.


Subject(s)
Complementarity Determining Regions/genetics , Drugs, Chinese Herbal/pharmacology , Genes, T-Cell Receptor beta , Liver Neoplasms/drug therapy , Animals , Gene Expression Regulation, Neoplastic , Liver Neoplasms/genetics , Random Allocation , Rats
5.
Scand J Immunol ; 81(2): 121-8, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25410477

ABSTRACT

γδT cells function as sentinels in early host responses to infections and malignancies. Previously, we found ectopically expressed human MutS homologue 2 (hMSH2), recognized by γδT cells, triggered a γδT cell-mediated cytolysis to tumor cells. However, the characteristics of hMSH2-specific γδ Τ cells are not fully understood. In this study, we investigated the complementary determinant region (CDR) 3δ diversity of hMSH2-specific γδ T cells. We found that the CDR3δ sequences of hMSH2-specific γδ T cells displayed limited diversity, while the length and germline gene usage showed no differences compared with whole CDR3δ immune repertoire. There are more hydrophilic amino acids in P/N insert of hMSH2-specific γδ T cells including the more conserved amino acid at the position 97. Our results offer clues to understanding antigen recognition pattern of γδ T cells to stress-induced hMSH2 of tumor cells and also the mechanism of γδT cell-mediated tumor immune surveillance.


Subject(s)
Complementarity Determining Regions/immunology , MutS Homolog 2 Protein/immunology , Receptors, Antigen, T-Cell, gamma-delta/immunology , T-Lymphocytes/immunology , Adult , Amino Acid Sequence , Amino Acids/chemistry , Amino Acids/genetics , Amino Acids/immunology , Blotting, Western , Cell Proliferation , Cells, Cultured , Complementarity Determining Regions/genetics , Female , Humans , Hydrophobic and Hydrophilic Interactions , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Male , Molecular Sequence Data , MutS Homolog 2 Protein/genetics , MutS Homolog 2 Protein/metabolism , Receptors, Antigen, T-Cell, gamma-delta/genetics , Recombinant Proteins/immunology , Recombinant Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocytes/metabolism
6.
Mucosal Immunol ; 8(2): 316-26, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25100291

ABSTRACT

A successful HIV-1 vaccine must elicit immune responses that impede mucosal virus transmission, though functional roles of protective HIV-1 Envelope (Env)-specific mucosal antibodies remain unclear. Colostrum is a rich source of readily accessible mucosal B cells that may help define the mucosal antibody response contributing to prevention of postnatal HIV-1 transmission. To examine the HIV-1 Env-specific colostrum B-cell repertoire, single B cells were isolated from 17 chronically HIV-infected, lactating women, producing 51 blood and 39 colostrum HIV-1 Env-specific B-cell antibodies. All HIV-1 Env-specific colostrum-derived antibodies were immunoglobulin (Ig)G1 isotype and had mean heavy chain complementarity-determining region 3 (CDR3) lengths and mutation frequencies similar to those isolated from blood. However, variable heavy chain (VH) gene subfamily 1(∼)69 usage was higher among colostrum than blood HIV-1 Env-reactive antibodies (49% vs. 20%, P=0.006, Fisher's exact test). Additionally, more HIV-1 Env-specific colostrum antibodies were gp120 specific than those isolated from blood (44% vs. 16%, P=0.005, Fisher's exact test). One cross-compartment HIV-1 Env-specific clonal B-cell lineage was identified. These unique characteristics of colostrum B-cell antibodies suggest selective homing of HIV-1-specific IgG1-secreting memory B cells to the mammary gland and have implications for targeting mucosal B-cell populations by vaccination.


Subject(s)
B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Colostrum/immunology , HIV Envelope Protein gp120/immunology , HIV Infections/genetics , HIV Infections/immunology , HIV-1/immunology , Lactation , Black or African American , Antibody Formation/immunology , B-Lymphocytes/cytology , CD4 Lymphocyte Count , Clonal Evolution , Colostrum/cytology , Complementarity Determining Regions/genetics , Epitopes, B-Lymphocyte/immunology , Female , HIV Antibodies/immunology , HIV Envelope Protein gp41/immunology , HIV Infections/blood , HIV Infections/transmission , HIV Infections/virology , Humans , Immunoglobulin G/blood , Immunoglobulin G/immunology , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Variable Region/genetics , Immunologic Memory , Immunophenotyping , Infectious Disease Transmission, Vertical , Mutation Rate , Phenotype , Somatic Hypermutation, Immunoglobulin , Viral Load
7.
Cell Res ; 23(2): 182-5, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23147791

ABSTRACT

The significant correlation between disease aggressiveness and the gene and protein structures of the B-cell receptors (BCRs) expressed on chronic lymphocytic leukemia (CLL) cells, together with the evidence for chronic activation of the BCR pathway, have led to the hypothesis that this leukemia initiates and progresses by selecting normal B lymphocytes reactive with a restricted set of (auto)antigens. A study recently published in Nature identified a novel signal-initiating interaction between the third complementary determining region of the IG heavy chain variable domain (HCDR3) and an epitope in the second framework region (FR2) that appears to be unique to CLL B cells and that calls into question the need for classical antigen binding in the activation and expansion of the leukemic cells. These findings are discussed in the context of available information about the antigen reactivity of CLL B cells and its potential role in clonal survival and drive.


Subject(s)
Leukemia, Lymphocytic, Chronic, B-Cell/metabolism , Receptors, Antigen, B-Cell/metabolism , Animals , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Calcium/metabolism , Complementarity Determining Regions/genetics , Complementarity Determining Regions/metabolism , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Mice , Mutation , Receptors, Antigen, B-Cell/chemistry , Receptors, Antigen, B-Cell/genetics , Signal Transduction
8.
PLoS One ; 7(1): e30295, 2012.
Article in English | MEDLINE | ID: mdl-22272329

ABSTRACT

The degradation of proteins by asparagine deamidation and aspartate isomerization is one of several chemical degradation pathways for recombinant antibodies. In this study, we have identified two solvent accessible degradation sites (light chain aspartate-56 and heavy chain aspartate-99/101) in the complementary-determining regions of a recombinant IgG1 antibody susceptible to isomerization under elevated temperature conditions. For both hot-spots, the degree of isomerization was found to be significantly higher than the deamidation of asparagine-(387, 392, 393) in the conserved CH3 region, which has been identified as being solvent accessible and sensitive to chemical degradation in previous studies. In order to reduce the time for simultaneous identification and functional evaluation of potential asparagine deamidation and aspartate isomerization sites, a test system employing accelerated temperature conditions and proteolytic peptide mapping combined with quantitative UPLC-MS was developed. This method occupies the formulation buffer system histidine/HCl (20 mM; pH 6.0) for denaturation/reduction/digestion and eliminates the alkylation step. The achieved degree of asparagine deamidation and aspartate isomerization was adequate to identify the functional consequence by binding studies. In summary, the here presented approach greatly facilitates the evaluation of fermentation, purification, formulation, and storage conditions on antibody asparagine deamidation and aspartate isomerization by monitoring susceptible marker peptides located in the complementary-determining regions of recombinant antibodies.


Subject(s)
Antibodies/metabolism , Asparagine/metabolism , Aspartic Acid/metabolism , Chromatography, Liquid/methods , Mass Spectrometry/methods , Amides/chemistry , Amides/metabolism , Amino Acid Sequence , Animals , Antibodies/chemistry , Antibodies/genetics , Asparagine/chemistry , Aspartic Acid/chemistry , CHO Cells , Complementarity Determining Regions/chemistry , Complementarity Determining Regions/genetics , Complementarity Determining Regions/metabolism , Cricetinae , Cricetulus , Hydrogen-Ion Concentration , Immunoglobulin G/chemistry , Immunoglobulin G/genetics , Immunoglobulin G/metabolism , Isomerism , Protein Binding , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid , Surface Plasmon Resonance , Temperature
9.
J Mol Biol ; 375(5): 1306-19, 2008 Feb 01.
Article in English | MEDLINE | ID: mdl-18155234

ABSTRACT

We report crystal structures of a negatively selected T cell receptor (TCR) that recognizes two I-A(u)-restricted myelin basic protein peptides and one of its peptide/major histocompatibility complex (pMHC) ligands. Unusual complementarity-determining region (CDR) structural features revealed by our analyses identify a previously unrecognized mechanism by which the highly variable CDR3 regions define ligand specificity. In addition to the pMHC contact residues contributed by CDR3, the CDR3 residues buried deep within the V alpha/V beta interface exert indirect effects on recognition by influencing the V alpha/V beta interdomain angle. This phenomenon represents an additional mechanism for increasing the potential diversity of the TCR repertoire. Both the direct and indirect effects exerted by CDR residues can impact global TCR/MHC docking. Analysis of the available TCR structures in light of these results highlights the significance of the V alpha/V beta interdomain angle in determining specificity and indicates that TCR/pMHC interface features do not distinguish autoimmune from non-autoimmune class II-restricted TCRs.


Subject(s)
Genetic Variation , Receptors, Antigen, T-Cell, alpha-beta/genetics , Receptors, Antigen, T-Cell/genetics , Alanine/metabolism , Amino Acid Substitution , Animals , Complementarity Determining Regions/chemistry , Complementarity Determining Regions/genetics , Complementarity Determining Regions/immunology , Complementarity Determining Regions/metabolism , Computer Simulation , Crystallography, X-Ray , DNA, Complementary , Epitopes , Escherichia coli/genetics , Glycine/metabolism , Hydrogen Bonding , Immunization , Ligands , Major Histocompatibility Complex/genetics , Major Histocompatibility Complex/immunology , Mice , Mice, Knockout , Models, Chemical , Models, Molecular , Mutagenesis, Site-Directed , Myelin Basic Protein/immunology , Peptides/chemistry , Peptides/immunology , Protein Conformation , Protein Structure, Tertiary , Receptors, Antigen, T-Cell, alpha-beta/chemistry , Receptors, Antigen, T-Cell, alpha-beta/immunology , Receptors, Antigen, T-Cell, alpha-beta/isolation & purification , Receptors, Antigen, T-Cell, alpha-beta/metabolism , Retroviridae/genetics , Selection, Genetic , Sensitivity and Specificity , Spodoptera/cytology , Surface Plasmon Resonance , Thymus Gland/immunology , Transfection
10.
J Immunol ; 178(10): 6320-31, 2007 May 15.
Article in English | MEDLINE | ID: mdl-17475861

ABSTRACT

Porcine respiratory and reproductive syndrome virus (PRRSV) causes an extraordinary increase in the proportion of B cells resulting in lymphoid hyperplasia, hypergammaglobulinemia, and autoimmunity in neonatal piglets. Spectratypic analysis of B cells from neonatal isolator piglets show a non-Gaussian pattern with preferential expansion of clones bearing certain H chain third complementary region (HCDR3) lengths. However, only in PRRSV-infected isolator piglets was nearly the identical spectratype observed for all lymphoid tissues. This result suggests dissemination of the same dominant B cell clones throughout the body. B cell expansion in PRRS was not associated with preferential VH gene usage or repertoire diversification and these cells appeared to bear a naive phenotype. The B cell population observed during infection comprised those with hydrophobic HCDR3s, especially sequences encoded by reading frame 3 of DHA that generates the AMVLV motif. Thus, the hydropathicity profile of B cells after infection was skewed to favor those with hydrophobic binding sites, whereas the normally dominant region of the hydropathicity profile containing neutral HCDR3s was absent. We believe that the hypergammaglobulinemia results from the products of these cells. We speculate that PRRSV infection generates a product that engages the BCR of naive B cells, displaying the AMVLV and similar motifs in HCDR3 and resulting in their T-independent proliferation without repertoire diversification.


Subject(s)
Antibodies, Viral/biosynthesis , Antibody Diversity/immunology , B-Lymphocyte Subsets/immunology , Cell Differentiation/immunology , Cell Proliferation , Complementarity Determining Regions/biosynthesis , Genitalia/immunology , Immunoglobulin Heavy Chains/biosynthesis , Porcine Reproductive and Respiratory Syndrome/immunology , Respiratory System/immunology , Animals , Animals, Newborn , Antibodies, Viral/blood , Antibodies, Viral/genetics , Antibody Diversity/genetics , B-Lymphocyte Subsets/cytology , B-Lymphocyte Subsets/metabolism , B-Lymphocyte Subsets/virology , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Cell Differentiation/genetics , Complementarity Determining Regions/blood , Complementarity Determining Regions/genetics , Fetus , Gene Rearrangement, B-Lymphocyte, Heavy Chain , Genitalia/virology , Hydrophobic and Hydrophilic Interactions , Immunoglobulin Heavy Chains/blood , Immunoglobulin Heavy Chains/genetics , Porcine Reproductive and Respiratory Syndrome/virology , Porcine respiratory and reproductive syndrome virus/immunology , Respiratory System/virology , Swine , Tissue Distribution/genetics , Tissue Distribution/immunology
11.
Int J Legal Med ; 120(2): 105-9, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16158311

ABSTRACT

We investigated two compresses used by Therese Neumann (T.N.), a woman who lived from 1898 until 1962 in Konnersreuth, Germany. The compresses were soaked with blood during the appearance of stigmata on T.N.'s body on a Friday. T.N. became very popular among the faithful in Germany at this time. The question was whether this blood was from T.N. herself or from a family relative or an animal. The comparison of the HV1 and HV2 mtDNA sequence obtained from the compresses with the sequences from a reference sample from a maternally related niece of T.N. revealed an identity. Furthermore, we obtained a short tandem repeat (STR) profile from the bloodstains that were identical with the STR profile from a gummed envelope. The envelope contained a letter written by T.N. in the 1930s. Therefore, our investigations gave no indication for any manipulation.


Subject(s)
Bandages , Christianity , DNA Fingerprinting , DNA, Mitochondrial/blood , Famous Persons , Blood Stains , Complementarity Determining Regions/genetics , Faith Healing/history , Female , Germany , History, 19th Century , History, 20th Century , Humans , Tandem Repeat Sequences
12.
J Mol Biol ; 335(1): 177-92, 2004 Jan 02.
Article in English | MEDLINE | ID: mdl-14659749

ABSTRACT

We describe a novel approach for high-throughput screening of recombinant antibodies, based on their immobilization on solid cellulose-based supports. We constructed a large human synthetic single-chain Fv antibody library where in vivo formed complementarity determining regions were shuffled combinatorially onto germline-derived human variable-region frameworks. The arraying of library-derived scFvs was facilitated by our unique display/expression system, where scFvs are expressed as fusion proteins with a cellulose-binding domain (CBD). Escherichia coli cells expressing library-derived scFv-CBDs are grown on a porous master filter on top of a second cellulose-based filter that captures the antibodies secreted by the bacteria. The cellulose filter is probed with labeled antigen allowing the identification of specific binders and the recovery of the original bacterial clones from the master filter. These filters may be simultaneously probed with a number of antigens allowing the isolation of a number of binding specificities and the validation of specificity of binders. We screened the library against a number of cancer-related peptides, proteins, and peptide-protein complexes and yielded antibody fragments exhibiting dissociation constants in the low nanomolar range. We expect our new antibody phage library to become a valuable source of antibodies to many different targets, and to play a vital role in facilitating high-throughput target discovery and validation in the area of functional cancer genomics.


Subject(s)
Antibodies/immunology , Complementarity Determining Regions/immunology , Gene Library , Immunoglobulin Fragments/immunology , Immunoglobulin Variable Region/immunology , Antibodies/genetics , Antigens, Neoplasm/immunology , Cellulose/chemistry , Combinatorial Chemistry Techniques , Complementarity Determining Regions/genetics , Drug Evaluation, Preclinical/methods , Escherichia coli/genetics , Humans , Immunoblotting , Immunoglobulin Fragments/genetics , Immunoglobulin Variable Region/genetics , Protein Binding , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/immunology
13.
Arthritis Rheum ; 46(5): 1270-81, 2002 May.
Article in English | MEDLINE | ID: mdl-12115233

ABSTRACT

OBJECTIVE: Investigators in this study undertook to determine whether in vitro antigen-responsive immune (polyomavirus T antigen [T-ag]- specific) and autoimmune (histone-specific) T cells from normal individuals share structural and genetic characteristics with those from patients with systemic lupus erythematosus (SLE). METHODS: Histone-specific T cells were generated by stimulation of peripheral blood mononuclear cells (PBMCs) with nucleosome-T-ag complexes and were subsequently maintained by pure histones. T-ag-specific T cell clones were initiated and maintained by T-ag. The frequencies of circulating histone- and T-ag-specific T cells were determined in healthy individuals and in SLE patients by limiting dilution of PBMCs. T cell receptor (TCR) gene usage and variable-region structures were determined by complementary DNA sequencing. These sequences were compared between T-ag- and histone-specific T cells and between normal individuals and SLE patients for each specificity. RESULTS: Individual in vitro-expanded histone- and T-ag-specific T cells from normal individuals displayed identical TCR V(alpha) and/or V(beta) chain third complementarity-determining region (CDR3) sequences, indicating that they were clonally expanded in vivo. The frequencies of in vitro antigen-responsive T-ag- or histone-specific T cells from normal individuals were similar to those from SLE patients. Although heterogeneous for variable-region structure and gene usage, histone-specific T cells from healthy individuals and SLE patients selected aspartic and/or glutamic acids at positions 99 and/or 100 of the V(beta) CDR3 sequence. CONCLUSION: Autoimmune T cells from healthy individuals can be activated by nucleosome- T-ag complexes and maintained by histones in vitro. Such T cells possessed TCR structures similar to those from SLE patients, demonstrating that T cell autoimmunity to nucleosomes may be a latent property of the normal immune system.


Subject(s)
Autoimmunity/immunology , Histones/immunology , Immune System/immunology , Nucleosomes/immunology , T-Lymphocytes/immunology , Adult , Amino Acids/genetics , Autoantigens/immunology , Autoimmunity/genetics , Cell Line , Cloning, Molecular , Complementarity Determining Regions/genetics , Female , Humans , Immunoglobulin Variable Region/genetics , In Vitro Techniques , Lupus Erythematosus, Systemic/genetics , Lupus Erythematosus, Systemic/immunology , Middle Aged , Receptors, Antigen, T-Cell, alpha-beta/genetics , T-Lymphocytes/cytology
14.
J Leukoc Biol ; 70(4): 537-42, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11590189

ABSTRACT

By itself, lipoteichoic acid (LTA) obtained from S. pyogenes, S. aureus, or E. hirae poorly stimulated cytokine production by macrophages, whereas in the presence of anti-polyglycerol phosphate (PGP), the cells secreted significant amounts of IL-6. Two peptides constructed from the deduced sequence of the selected anti-PGP phage-antibody's complementary-determining region 3 of the variable heavy chain (V(H)-CDR3) reacted specifically with PGP. The monomeric form of the peptides markedly inhibited cytokine production by macrophages pretreated with LTA and anti-LTA. In contrast, the polyvalent form of biotinylated peptides complex with streptavidin-induced cytokine production by the LTA-treated macrophages. The data taken together support the concept that cross-linking of macrophage-bound LTA by anti-PGP is required for cytokine release by these cells. Importantly, these studies identified small, PGP-reactive peptides as potential tools in reducing this proinflammatory process.


Subject(s)
Antibodies/pharmacology , Glycerophosphates/immunology , Lipopolysaccharides/pharmacology , Macrophages/immunology , Monocytes/immunology , Teichoic Acids/pharmacology , Amino Acid Sequence , Cells, Cultured , Complementarity Determining Regions/genetics , Complementarity Determining Regions/immunology , Humans , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Heavy Chains/immunology , Interleukin-6/biosynthesis , Lipopolysaccharides/immunology , Macrophages/drug effects , Molecular Sequence Data , Monocytes/drug effects , Peptide Library , Peptides/immunology , Peptides/pharmacology , Teichoic Acids/immunology
15.
J Immunol ; 166(4): 2540-52, 2001 Feb 15.
Article in English | MEDLINE | ID: mdl-11160315

ABSTRACT

The process of V(D)J recombination that leads to the assembly of Ig gene segments is tightly controlled during B cell differentiation. Two germline transcripts, one of which (mu(0)) originates from the promoter region of DQ52, may control the accessibility of the heavy chain locus. Here, we present the analysis of a mouse line in which the DQ52 gene together with its regulatory sequences is deleted by a Cre/loxP-based strategy. In F(1) (DQ52(+/-)) mice, the use of the JH3 and JH4 elements in DJ or VDJ junctions of the DQ52(-) allele was strongly reduced in both the bone marrow pre-B and spleen cells, while the JH1 and JH2 elements were used with normal frequencies. In addition, IgM(+) B cells of bone marrow and spleen used the DQ52(-) allele less frequently. On DJ joints of the DQ52(-) allele, there was 2 times less processing of JH3 ends, which resulted in clearly increased addition of P nucleotides. Although the use of D elements in DJ joints was quite similar, an altered D repertoire was found in VDJ joints of the DQ52(-) allele. In splenic B cells of the DQ52(-/-) mouse the amino acid distribution of the CDR3 was skewed, probably to compensate for the altered processing of JH3 ends. Thus, we have shown an interesting selective effect of the DQ52 region on controlling accessibility to 3' JH elements on the Ig locus, which also seems to influence the processing of DJ joints. We propose a model in which the DQ52 promoter region enhances the induction of secondary DJ rearrangements.


Subject(s)
Antibody Diversity/genetics , Gene Deletion , Gene Rearrangement, B-Lymphocyte, Heavy Chain , Genes, Immunoglobulin , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Variable Region/genetics , Regulatory Sequences, Nucleic Acid/immunology , Alleles , Amino Acid Sequence , Amino Acids/analysis , Animals , B-Lymphocyte Subsets/immunology , B-Lymphocyte Subsets/pathology , Base Sequence , Complementarity Determining Regions/genetics , Complementarity Determining Regions/metabolism , DNA, Complementary/isolation & purification , Gene Targeting , Genetic Markers/immunology , Immunoglobulin Heavy Chains/biosynthesis , Immunoglobulin Heavy Chains/metabolism , Immunoglobulin Joining Region/biosynthesis , Immunoglobulin Joining Region/genetics , Immunoglobulin Joining Region/metabolism , Immunoglobulin Variable Region/biosynthesis , Immunoglobulin Variable Region/metabolism , Immunoglobulin mu-Chains/genetics , Immunoglobulin mu-Chains/isolation & purification , Lymphocyte Count , Lymphopenia/genetics , Lymphopenia/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Molecular Sequence Data , Protein Processing, Post-Translational/genetics , Protein Processing, Post-Translational/immunology , Transcription, Genetic/immunology
SELECTION OF CITATIONS
SEARCH DETAIL